Skip to main content
SpringerLink
Log in

Vitamin E analogs: A new class of multiple action agents with anti-neoplastic and anti-atherogenic activity

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

The incidence of cancer and atherosclerosis, two most common causes of death in developed countries, has been stagnating or, even, increasing. Drugs effective against such conditions are needed and, in this regard, the potential anti-atherosclerotic activity of vitamin E analogs has been studied extensively. Surprisingly, recent results indicate that these agents may also exert anti-neoplastic effects. Here we review the evidence that particular analogs of vitamin E may act as both antiatherogenic and anti-cancer agents, and discuss the possible molecular bases for these actions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burton GW, Traber MG Vitamin E: Antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990; 10: 357–382.

    Google Scholar 

  2. Neuzil J, Weber T, Schröder A, et al. Induction of apoptosis in cancer cells by α-tocopheryl succinate: Molecular pathways and structural requirements. FASEB J 2001; 15: 403–415.

    Google Scholar 

  3. Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, Djuric Z The selective antiproliferative effects of α-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res 1994; 54: 3346–3351.

    Google Scholar 

  4. Turley JM, Funakoshi S, Ruscetti FW, et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor-β. Cell Growth Differ 1995; 6: 655–663.

    Google Scholar 

  5. Qian M, Kralova J, Yu W, et al. c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene 1997; 15: 223–230.

    Google Scholar 

  6. Pussinen PJ, Lindner H, Glatter O, et al. Lipoprotein-associated α-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochim Biophys Acta 2000; 1485: 129–144.

    Google Scholar 

  7. Neuzil J, Weber T, Gellert N, Weber C Selective cancer cell killing by α-tocopheryl succinate. Br J Cancer 2001; 84: 87–89.

    Google Scholar 

  8. Tirmenstein MA, Ge X, Elkins CR, Fariss MW Administration of the tris salt of α-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal α-tocopherol levels and protects against carbon tetrachloride-induced hepatotoxicity. Free Radic Biol Med 1999; 26: 825–835.

    Google Scholar 

  9. Borel P, Pasquier B, Armand M, et al. Processing of vitamin A and E in the human gastrointestinal tract. Am J Physiol 2001; 280: G95-G103.

    Google Scholar 

  10. Kayden HJ, Traber MG Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 1993; 34: 343–358.

    Google Scholar 

  11. Fariss MW, Bryson KF, Hylton EE, Lippman HR, Stubin CH, Zhao XG Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol. Environ Health Perspect 1993; 101: 528–536.

    Google Scholar 

  12. Burton GW, Ingold KU Vitamin E: Application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res 1986; 19: 194–201.

    Google Scholar 

  13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924.

    Google Scholar 

  14. Ross R Atherosclerosis—An inflammatory disease. New Engl J Med 1999; 340: 115–126.

    Google Scholar 

  15. Neuzil J, Thomas SR, Stocker R Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 1997; 22: 57–71.

    Google Scholar 

  16. Azzi A, Stocker A Vitamin E: Non-antioxidant roles. Progr Lipid Res 2000; 39: 231–255.

    Google Scholar 

  17. Neuzil J, Weber C, Kontush A Vitamin E in atherosclerosis: Linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 2001; 157: 257–283.

    Google Scholar 

  18. Heinecke JW Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998; 141: 1–15.

    Google Scholar 

  19. Niu X, Zammit V, Upston JM, Dean RT, Stocker R Coexistence of oxidized lipids and α-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1999; 19: 1708–1718.

    Google Scholar 

  20. Thomas SR, Neuzil J, Stocker R Co-supplementation with ubiquinone-10 inhibits the pro-oxidant activity of α-tocopherol in transition metal-mediated oxidation of isolated low-density lipoprotein. Arterioscler Thromb Vasc Biol 1996; 16: 687–696.

    Google Scholar 

  21. Neuzil J, Witting PK, Stocker R α-Tocopheryl hydroquinone is an efficient multi-functional inhibitor of radical-initiated oxidation of low-density lipoprotein lipids. Proc Natl Acad Sci USA 1997; 94: 7885–7890. J. Neuzil et al.

    Google Scholar 

  22. Keaney JF, Simon DI, Freedman JE Vitamin E and vascular homeostasis: Implications for atherosclerosis. FASEB J 1999; 13: 965–976.

    Google Scholar 

  23. Devaraj S, Jialal I The effects of α-tocopherol on critical cells in atherogenesis. Curr Opinion Lipidol 1998; 9: 11–15.

    Google Scholar 

  24. Barnes PJ, Karin M Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066–1071.

    Google Scholar 

  25. Sen CK, Packer L Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709–720.

    Google Scholar 

  26. Faruqi R, de la Motte C, DiCorleto PE α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 1994; 94: 592–600.

    Google Scholar 

  27. Devaraj S, Li D, Jialal I The effects of α-tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1-β secretion, and monocyte adhesion to endothelium. J Clin Invest 1996; 98: 756–763.

    Google Scholar 

  28. Ricciarelli R, Zingg JM, Azzi A Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000; 102: 82–87.

    Google Scholar 

  29. Neuzil J, Schr¨oder A, von Hundelshausen P, et al. Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. Biochemistry 2001; 40: 4686–4692.

    Google Scholar 

  30. Erl W, Weber C, Wardemann C, Weber PC α-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-κB mobilization. Am J Physiol 1997; 273: H634–640.

    Google Scholar 

  31. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop. Nat Cell Biol 1999; 1: 227–233.

    Google Scholar 

  32. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat Med 1998; 4: 1189–1192.

    Google Scholar 

  33. Tangirala RK, Pratico D, FitzGerald GA, et al. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. J Biol Chem 2001; 276: 261–266.

    Google Scholar 

  34. Terasawa Y, Ladha Z, Leonard SW, et al. Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA 2000; 97: 13830–13834.

    Google Scholar 

  35. Thomas SR, Leichtweis SB, Pettersson K, et al. Dietary cosupplementation with vitamin E and coenzyme Q-10 inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 2001; 21: 585–593.

    Google Scholar 

  36. Pryor WA Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141–164.

    Google Scholar 

  37. Neuzil J, Svensson I, Weber T, Weber C, Brunk UT α-Tocopheryl succinate-induced apoptosis in Jurkat T cells involves caspase-3 activation, and both lysosomal and mitochondrial destabilisation. FEBS Lett 1999; 445: 295–300.

    Google Scholar 

  38. Neuzil J, Ostermann G, Sticha M, Gellert N, Weber C, Eaton JW, Brunk UT α-Tocopheryl succinate, an agent with in vivo anti-tumour activity, induces apoptosis by causing lysosome instability. Biochem J (in press).

  39. Gottlieb RA Mitochondria: Execution central. FEBS Lett 2000; 482: 6–12.

    Google Scholar 

  40. Brunk UT, Neuzil J, Eaton JW The role of lysosomes in apoptosis. Redox Report 2001; 6: 91–97.

    Google Scholar 

  41. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A Cathepsin D protease mediates programmed cell death induced by interferon-γ, Fas/APO-1 and TNFα. EMBO J 1996; 15: 3861–3870.

    Google Scholar 

  42. Guicciardi ME, Deussing J, Miyoshi H, et al. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106: 1127–1137.

    Google Scholar 

  43. Yuan XM, Li W, Brunk UT, Dalen H, Chang YH, Sevanian A Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radic Biol Med 2000; 28: 208–218.

    Google Scholar 

  44. Roberg K, Öllinger K Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998; 152: 1151–1156.

    Google Scholar 

  45. Roberg K, Johansson U, Öllinger K Lysosomal release of cathepsinDprecedes relocation of cytocrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 1999; 27: 1228–1237.

    Google Scholar 

  46. Kågedal K, Johansson U, Ôllinger K The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 2001; 15: 1592–1594.

    Google Scholar 

  47. Hishita T, Tada-Oikawa S, Tohyama K, et al. Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Cancer Res 2001; 61: 2878–2884.

    Google Scholar 

  48. Stoka V, Turk B, Schendel SL, et al. Lysosomal protease pathways to apoptosis. Cleavage of Bid, not pro-caspases, is the most likely route. J Biol Chem 2001; 276: 3149–3157.

    Google Scholar 

  49. Wu GS, Saftig P, Peters C, El-Deiry WS Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998; 16: 2177–2183.

    Google Scholar 

  50. Yamamoto S, Tamai H, Ishisaka R, et al. Mechanism of α-tocopheryl succinate-induced apoptosis of promyelocytic leukemia cells. Free Radic Res 33: 407–418.

  51. Neuzil J, Weber T, Weber C, Terman A, Brunk U Vitamin E analogs as inducers of apoptosis: Application for potential cancer treatment. Redox Report 2001; 6: 143–151.

    Google Scholar 

  52. Turley JM, Ruscetti FW, Kim SJ, Fu T, Gou FV, Birchenall-Roberts MC Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res 1997; 57: 2668–2675.

    Google Scholar 

  53. Gogu SR, Lertora JJ, George WJ, Hyslop NE, Agrawal KC Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E. Exp Hematol 1991; 19: 649–652.

    Google Scholar 

  54. Weber T, Lu M, Andera L, et al. Vitamin E succinate is a potent novel anti-neoplastic agent with high tumor selectivity and cooperativity with TRAIL in vivo. Clin Canc Res (in press).

  55. Malafa MP, Neitzel LT Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000; 93: 163–170.

    Google Scholar 

  56. Albanes D, Malila N, Taylor PR, et al. Effects of supplemental α-tocopherol and β-carotene on colorectal cancer: Results from a controlled trial. Cancer Causes Control 2000; 11: 197–205.

    Google Scholar 

  57. Walczak H Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157–163.

    Google Scholar 

  58. French LE, Tschopp J The TRAIL to selective tumor death. Nat Med 1999; 5: 146–147.

    Google Scholar 

  59. Bonavida B, Ng CP, Jazirehi A, Schiller G, Mizutani Y Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics. Int J Oncol 1999; 15: 793–802.

    Google Scholar 

  60. Nagane M, Huang HJ, Cavenee WK The potential of TRAIL for cancer chemotherapy. Apoptosis 2001; 6: 191–197.

    Google Scholar 

  61. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 2001; 61: 759–763.

    Google Scholar 

  62. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 2000; 60: 847–853.

    Google Scholar 

  63. Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 1999; 59: 734–741.

    Google Scholar 

  64. Chinnaiyan AM, Prasad U, Shankar S, et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000; 97: 1754–1759.

    Google Scholar 

  65. Cheeseman KH, Holley AE, Kelly FJ, Wasil M, Hughes L, Burton G Biokinetics in humans of RRR-α-tocopherol: The free phenol, acetate ester, and succinate ester forms of vitamin E. Free Radic Biol Med 19: 591–598.

  66. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 2000; 97: 11494–11499.

    Google Scholar 

  67. Traber MG, Ramakrishnan R, Kayden HJ Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-α-tocopherol. Proc Natl Acad Sci USA 1994; 91: 10005–10008.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pathology II, University Hospital, Linköping, Sweden;

    J. Neuzil, K. Kågedal & U. T. Brunk

  2. Institute for Prevention of Cardiovascular Diseases, Ludwig Maximilians University, Munich, Germany;

    J. Neuzil & C. Weber

  3. Heart Foundation Research Center, School of Health Sciences, Griffith University, Gold Coast Campus, Southport, Australia

    J. Neuzil

  4. Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic

    L. Andera

  5. Department of Cardiovascular Molecular Biology, University Hospital, Aachen, Germany

    C. Weber

Authors
  1. J. Neuzil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Kågedal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Andera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. T. Brunk
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neuzil, J., Kågedal, K., Andera, L. et al. Vitamin E analogs: A new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 7, 179–187 (2002). https://doi.org/10.1023/A:1014378901843

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014378901843

Search

Navigation